Beiley Biofund

Beiley Biofund Graham Number

The Graham Number of Beiley Biofund (7882.TWO) as of Nov 4, 2026 is 10.69 TWD. In the previous year, Graham Number was 10.02 TWD — a change of 6.70% (higher).

Graham Number

10.69TWD

YoY

6.70%

Last updated:

Graham Number of Beiley Biofund is 2024 10.69 TWD. Graham Number of Beiley Biofund was 2023 10.02 TWD. It decreases by 6.70% higher compared to the previous year.

The Beiley Biofund Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2023
10.02 TWD
Jan 1, 2024
10.69 TWD
The Beiley Biofund Graham Number history
YEARGraham NumberYoY
10.69TWD+6.70%
10.02TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beiley Biofund Stock analysis

What does Beiley Biofund do? Beiley Biofund Inc generates revenue through venture capital investments in biotechnology and healthcare sectors. The company focuses on new drug and pharmaceutical R&D, advanced medical devices, pharmaceutical manufacturing, diagnostics, precision medicine, innovative medical service technologies, healthcare networks, and agricultural biotechnology. Its primary investment scope is domestic, targeting companies within Taiwan's biotech industry. The firm's revenue comes from capital gains and returns on its portfolio investments in these specialized areas. Beiley Biofund Inc operates as a Taiwan-based venture capital firm with a domestic investment focus. It targets biotechnology and healthcare companies developing innovative solutions in drug development, medical devices, and precision medicine. The firm's investment strategy centers on companies within Taiwan's biotech ecosystem, providing capital for growth and innovation. Revenue is derived from successful exits and equity appreciation in its portfolio companies. The company's investment areas include pharmaceutical manufacturing and services, diagnostics, precision medicine, and agricultural biotechnology. Beiley Biofund Inc concentrates on firms within Taiwan's domestic market, making capital available for biotech startups and established players. Revenue is generated through the financial performance of its investment portfolio in these specific sectors. Beiley Biofund is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beiley Biofund stock

Graham Number of Beiley Biofund is 10.69 TWD in 2024.

On Eulerpool you can find the complete historical development of Graham Number Beiley Biofund since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Beiley Biofund

All Key Metrics — Beiley Biofund